Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

News

Lobe Sciences Announces Pending Patents and Preclinical Research Studies

Vancouver 2/5/2021 2:00:00 PM

Lobe Sciences Ltd. GTSIF focuses on mastering the development of transformational medicines and devices as we build a growing portfolio of intellectual property to support wellness and improve mental health. We focus on clinical development of devices and the use of psychedelic medicines to treat specific indications and brain traumas. We are a dedicated team of pioneering scientists, engineers, and operators committed to the investigation and development of treatments using alternative and nontraditional mechanisms for better health. We are announcing pending patents and preclinical research that includes:

- Psilocybin combined with NAC for the treatment of mTBI and PTSD and other conditions.

- MDMA combined with NAC for the treatment of mTBI and PTSD and other conditions

- Addition of compounds to create memory odor imprint pairing

- Nasal Mist Transducer Device for deilvery of medicines directly to the Olfactory Bulb

- Virtual Reality Headset combined with Nasal Mist Device.

Lobe Sciences Ltd. has launched a preclinical research study using psilocybin and 
N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injury/concussion 
(“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with 
a multidisciplinary team of scientists and physicians at the University of Miami's Miller 
School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

For more information, get in touch with Lobe Sciences Ltd. GTSIF by contacting us at 604-834-9499.

More News

https://s3.amazonaws.com/findit-pictures/351842/c03c2767-2f29-496d-8b3b-ecd7609be798.jpg

Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products

Released On: 5/19/2021
Views: 376

https://s3.amazonaws.com/findit-pictures/351842/7c3f472e-c97f-45ff-9c08-819040bade92.jpg

Lobe Sciences to Present at the Benzinga Global Small Cap Conference

Lobe Sciences to Present at the Benzinga Global Small Cap Conference

Released On: 5/6/2021
Views: 334

https://s3.amazonaws.com/findit-pictures/351842/b1f163f0-58c3-4603-ad97-39d4324f5f1b.jpg

Lobe Sciences Acquires Vitamind Line of Wellness Products

Lobe Sciences Acquires Vitamind Line of Wellness Products

Released On: 5/4/2021
Views: 295

https://s3.amazonaws.com/findit-pictures/351842/fa37cd64-93b0-430e-b367-33465c72bbe2.jpg

Lobe Sciences Announces Filing of PCT Application

Lobe Sciences Announces Filing of PCT Application

Released On: 4/29/2021
Views: 279

https://s3.amazonaws.com/findit-pictures/351842/326d08e6-4451-4e58-89f0-53559d5a35fa.jpg

Lobe Sciences Retains Jolt Communications to Increase Investor Awareness

Lobe Sciences Retains Jolt Communications to Increase Investor Awareness

Released On: 2/12/2021
Views: 559

https://s3.amazonaws.com/findit-pictures/351842/9850dc5a-3373-48c5-9e73-5d1455ced965.jpg

Meet Lobe Sciences A Life Sciences Company Focused on Psychedelic Medicines

Meet Lobe Sciences A Life Sciences Company Focused on Psychedelic Medicines

Released On: 2/8/2021
Views: 768

https://s3.amazonaws.com/findit-pictures/351842/4c09e4fc-33d0-4ee5-ad58-0eed22ea966f.jpg

Lobe Sciences Announces Pending Patents and Preclinical Research Studies

Lobe Sciences Announces Pending Patents and Preclinical Research Studies

Released On: 2/5/2021
Views: 483

https://s3.amazonaws.com/findit-pictures/351842/a6477493-5cd1-4e34-93af-4ce00362040d.jpg

Lobe Sciences Announces Management Changes and New Director

Lobe Sciences Announces Management Changes and New Director

Released On: 1/18/2021
Views: 424

https://s3.amazonaws.com/findit-pictures/351842/bf8e59b3-05ec-4702-8c04-c9573f50fcd7.jpg

Lobe Sciences Announces Changes to Board of Directors

Lobe Sciences Announces Changes to Board of Directors

Released On: 1/8/2021
Views: 401

https://s3.amazonaws.com/findit-pictures/351842/fcbc3698-30db-4aa8-91ea-a8f9318d4d97.jpg

Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors

Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors

Released On: 12/14/2020
Views: 389

https://s3.amazonaws.com/findit-pictures/351842/644126cf-4f77-4ead-9cfe-585dfbd107f3.jpg

Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Released On: 12/1/2020
Views: 337

https://s3.amazonaws.com/findit-pictures/351842/0ef6e34c-ab49-4943-b466-4e5e6089f62f.jpg

Lobe Sciences Announces Launch of Preclinical Study in Collaboration with the University of Miami Miller School of Medicine

Lobe Sciences Announces Launch of Preclinical Study in Collaboration with the University of Miami Miller School of Medicine

Released On: 11/30/2020
Views: 332

wait

Map

LOBE SCIENCES LTD.

Get Directions

LOBE SCIENCES LTD.

  • 422 Richards Street Suite 170
    Vancouver, BC V6b 2Z4
    Canada
  • 604-834-9499